Therapeutic targets and early stage clinical trials for pulmonary fibrosis
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Therapeutic targets and early stage clinical trials for pulmonary fibrosis
Authors
Keywords
-
Journal
EXPERT OPINION ON INVESTIGATIONAL DRUGS
Volume 28, Issue 1, Pages 19-28
Publisher
Informa UK Limited
Online
2018-12-05
DOI
10.1080/13543784.2019.1554054
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Newly Discovered Antifibrotic Pathway Regulated by Two Fatty Acid Receptors
- (2018) Lyne Gagnon et al. AMERICAN JOURNAL OF PATHOLOGY
- Do Randomized Clinical Trials Always Provide Certain Results? The Case of Tralokinumab in Idiopathic Pulmonary Fibrosis
- (2018) Mark G. Jones et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- A Phase 2 Randomized Controlled Study of Tralokinumab in Subjects with Idiopathic Pulmonary Fibrosis
- (2018) Joseph M. Parker et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Nintedanib with Add-on Pirfenidone in Idiopathic Pulmonary Fibrosis. Results of the INJOURNEY Trial
- (2018) Carlo Vancheri et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Mesenchymal Stem Cell Therapy of Pulmonary Fibrosis
- (2018) Hong-Meng Chuang et al. CELL TRANSPLANTATION
- The increasing mortality of idiopathic pulmonary fibrosis: fact or fallacy?
- (2018) Christopher J. Ryerson et al. EUROPEAN RESPIRATORY JOURNAL
- Effect of Recombinant Human Pentraxin 2 vs Placebo on Change in Forced Vital Capacity in Patients With Idiopathic Pulmonary Fibrosis
- (2018) Ganesh Raghu et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- The anti-fibrotic agent, tipelukast (MN-001) reduces serum triglyceride significantly in non-alcoholic steatohepatitis and non-alcoholic fatty liver disease patients with hypertriglyceridemia after 4 weeks of treatment, an interim analysis of ongoing clinical trial, MN-001-NATG-201
- (2018) K. Matsuda et al. JOURNAL OF HEPATOLOGY
- Transcription Factor NRF2 as a Therapeutic Target for Chronic Diseases: A Systems Medicine Approach
- (2018) Antonio Cuadrado et al. PHARMACOLOGICAL REVIEWS
- Nanoscale dysregulation of collagen structure-function disrupts mechano-homeostasis and mediates pulmonary fibrosis
- (2018) Mark G Jones et al. eLife
- SAR156597 in idiopathic pulmonary fibrosis: a phase 2 placebo-controlled study (DRI11772)
- (2018) Ganesh Raghu et al. EUROPEAN RESPIRATORY JOURNAL
- Idiopathic pulmonary fibrosis: lessons from clinical trials over the past 25 years
- (2017) Ganesh Raghu EUROPEAN RESPIRATORY JOURNAL
- Idiopathic pulmonary fibrosis
- (2017) Luca Richeldi et al. LANCET
- Efficacy of simtuzumab versus placebo in patients with idiopathic pulmonary fibrosis: a randomised, double-blind, controlled, phase 2 trial
- (2017) Ganesh Raghu et al. Lancet Respiratory Medicine
- Stretch-induced Activation of Transforming Growth Factor-β1in Pulmonary Fibrosis
- (2016) Aaron R. Froese et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Epidemiology and survival of idiopathic pulmonary fibrosis from national data in Canada
- (2016) Robert B. Hopkins et al. EUROPEAN RESPIRATORY JOURNAL
- FG-3019 anti-connective tissue growth factor monoclonal antibody: results of an open-label clinical trial in idiopathic pulmonary fibrosis
- (2016) Ganesh Raghu et al. EUROPEAN RESPIRATORY JOURNAL
- Recombinant human pentraxin-2 therapy in patients with idiopathic pulmonary fibrosis: safety, pharmacokinetics and exploratory efficacy
- (2016) Bernt van den Blink et al. EUROPEAN RESPIRATORY JOURNAL
- Autotaxin activity increases locally following lung injury, but is not required for pulmonary lysophosphatidic acid production or fibrosis
- (2016) Katharine E. Black et al. FASEB JOURNAL
- Health-Related Quality of Life in Patients with Idiopathic Pulmonary Fibrosis
- (2016) Susan E. Yount et al. LUNG
- Promising Pharmacological Directions in the World of Lysophosphatidic Acid Signaling
- (2015) Nicole C. Stoddard et al. Biomolecules & Therapeutics
- Why do patients get idiopathic pulmonary fibrosis? Current concepts in the pathogenesis of pulmonary fibrosis
- (2015) Pierre-Simon Bellaye et al. BMC Medicine
- Global incidence and mortality of idiopathic pulmonary fibrosis: a systematic review
- (2015) John Hutchinson et al. EUROPEAN RESPIRATORY JOURNAL
- Stem Cell-Based Therapy in Idiopathic Pulmonary Fibrosis
- (2015) Marek Barczyk et al. Stem Cell Reviews and Reports
- Stem Cell-Based Therapy in Idiopathic Pulmonary Fibrosis
- (2015) Marek Barczyk et al. Stem Cell Reviews and Reports
- Activated alveolar epithelial cells initiate fibrosis through autocrine and paracrine secretion of connective tissue growth factor
- (2014) Jibing Yang et al. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
- Targeting Interleukin-13 with Tralokinumab Attenuates Lung Fibrosis and Epithelial Damage in a Humanized SCID Idiopathic Pulmonary Fibrosis Model
- (2014) Lynne A. Murray et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Inhibition of mechanosensitive signaling in myofibroblasts ameliorates experimental pulmonary fibrosis
- (2013) Yong Zhou et al. JOURNAL OF CLINICAL INVESTIGATION
- Structural Basis of Signaling Blockade by Anti-IL-13 Antibody Lebrikizumab
- (2013) Mark Ultsch et al. JOURNAL OF MOLECULAR BIOLOGY
- The Novel VEGF Receptor/MET-Targeted Kinase Inhibitor TAS-115 Has Marked In Vivo Antitumor Properties and a Favorable Tolerability Profile
- (2013) H. Fujita et al. MOLECULAR CANCER THERAPEUTICS
- The Triterpenoid CDDO-Me Inhibits Bleomycin-Induced Lung Inflammation and Fibrosis
- (2013) Ajit A. Kulkarni et al. PLoS One
- Pulmonary Autotaxin Expression Contributes to the Pathogenesis of Pulmonary Fibrosis
- (2012) Nikos Oikonomou et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Octreotide treatment of idiopathic pulmonary fibrosis: a proof-of-concept study
- (2012) B. Crestani et al. EUROPEAN RESPIRATORY JOURNAL
- The pathogenesis of pulmonary fibrosis: a moving target
- (2012) Wim A. Wuyts et al. EUROPEAN RESPIRATORY JOURNAL
- Pulmonary fibrosis: patterns and perpetrators
- (2012) Paul W. Noble et al. JOURNAL OF CLINICAL INVESTIGATION
- Poster Sessions
- (2012) Eugen Dhimolea et al. mAbs
- Mechanisms of fibrosis: therapeutic translation for fibrotic disease
- (2012) Thomas A Wynn et al. NATURE MEDICINE
- An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and Management
- (2011) Ganesh Raghu et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Regulation of Transforming Growth Factor-β1–driven Lung Fibrosis by Galectin-3
- (2011) Alison C. MacKinnon et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- The Lysophosphatidic Acid Receptor LPA1Promotes Epithelial Cell Apoptosis after Lung Injury
- (2011) Manuela Funke et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Epithelial-Mesenchymal Interactions in Pulmonary Fibrosis
- (2011) Harold A. Chapman Annual Review of Physiology
- Preclinical development of CAT-354, an IL-13 neutralizing antibody, for the treatment of severe uncontrolled asthma
- (2011) RD May et al. BRITISH JOURNAL OF PHARMACOLOGY
- Plasma CCN2 (connective tissue growth factor; CTGF) is a potential biomarker in idiopathic pulmonary fibrosis (IPF)
- (2011) Masato Kono et al. CLINICA CHIMICA ACTA
- Clinical Course and Prediction of Survival in Idiopathic Pulmonary Fibrosis
- (2010) Brett Ley et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Alternatively activated alveolar macrophages in pulmonary fibrosis—mediator production and intracellular signal transduction
- (2010) Dmitri V. Pechkovsky et al. CLINICAL IMMUNOLOGY
- PRM-151 (recombinant human serum amyloid P/pentraxin 2) for the treatment of fibrosis
- (2010) J.S. Duffield et al. DRUG NEWS & PERSPECTIVES
- TGF-beta driven lung fibrosis is macrophage dependent and blocked by Serum amyloid P
- (2010) Lynne A. Murray et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Serum Amyloid P Therapeutically Attenuates Murine Bleomycin-Induced Pulmonary Fibrosis via Its Effects on Macrophages
- (2010) Lynne A. Murray et al. PLoS One
- Interleukin-13 and Its Receptors in Idiopathic Interstitial Pneumonia: Clinical Implications for Lung Function
- (2009) Sung-Woo Park et al. JOURNAL OF KOREAN MEDICAL SCIENCE
- Pivotal Advance: Th-1 cytokines inhibit, and Th-2 cytokines promote fibrocyte differentiation
- (2008) D. D. Shao et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Partial Inhibition of Integrin αvβ6 Prevents Pulmonary Fibrosis without Exacerbating Inflammation
- (2007) Gerald S. Horan et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Activation of somatostatin receptors attenuates pulmonary fibrosis
- (2007) R Borie et al. THORAX
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search